Cell Therapy Development
& Manufacturing
Get your product to patients. Now.
At NecstGen, we recognise the immense potential of cell therapy – a frontier of medical science that requires exclusive expertise and the most advanced technologies. Our mission is to aid researchers and enterprises by mitigating risks, ensuring a swift path to market and maintaining adaptability for evolving strategies.
Partnering with Us, You Accelerate Your Path to Market
NecstGen is not just a vendor; we are your development partner for academics and industry. Our complete, end-to-end solution enables seamless progression from concept to clinical trial, creating a smoother, more efficient path to market.
We facilitate translational activities to create GMP-compliant manufacturing, ensuring your work meets the highest regulatory standards. Our process design and optimisation services streamline the path from laboratory to clinic. We also offer solutions for scale-up to clinically relevant volumes, along with automation and closed processes, making production more efficient and robust.
A Wide Range of Cell Therapies
Our portfolio covers an extensive range of cell therapies. Talk to us about your requirements for:
iPSC
Induced Pluripotent Stem Cells
CAR T
Chimeric Antigen Receptor T Cells
TIL
Tumor Infiltrating Lymphocytes
NK
Natural Killer Cells/CAR NK Cells
DC
Dendritic Cells
MSC
Mesenchymal Stromal Cells
TCR T
T Cell Receptor Modified T Cells
Navigate the Future of CGT with NecstGen
We stand at the intersection of science and technology, where expertise meets innovation. Our comprehensive services, tailored solutions, and scientific insight set us apart, ensuring that you can confidently navigate the complex landscape of cell therapy development and manufacturing.
Let NecstGen be your partner in this journey. Contact us today, and let’s push the boundaries of what’s possible together.
Watch the replay
iPSC Derivation & Banking
Learn to develop and implement GMP-compliant iPSC processes, from derivation to quality control.
